Microcirculatory Vasomotor Changes in Type 2 Diabetes With Peripheral Neuropathy

Study Overview
=================
Brief Summary
-----------------
Microcirculatory flow is subject to cyclic changes under the influence of heart rate, respiration, myogenic activity, neurogenic factors and endothelial factors. Microcirculatory oscillations (vasomotion) contribute significantly to tissue perfusion. Vasomotion analysis allowed to discriminate normoglycemic subjects, prediabetic subjects and diabetic subjects. Furthermore, changes in vasomotion can precede the emergence of global signs of microangiopathy complications in type 2 diabetes. In fact, few studies reported impaired vasomotion in type 2 diabetes with peripheral neuropathy. Vasomotion analysis after vasodilator (6-min walking test and hyperthermia) and after vasoconstrictor (foot lowering) stimulus could be an effective diagnostic tool to sharpen the diagnostic. Objectives and Methodology: to study vasomotion at baseline and after exercise, hyperthermia and foot lowering within 3 groups of patients: diabetic without peripheral neuropathy, diabetic with subclinical peripheral neuropathy and diabetic with peripheral neuropathy and one group of sex- age- and body mass index-matched healthy control subjects. All the subjects will benefit from a clinical, anthropometric, level of physical activity and biological evaluations. Type 2 diabetes participants will benefit from neuropathy evaluation. In addition, cutaneous microcirculation (perfusion and vasomotion) by means of Laser Doppler Flowmetry and Laser Speckle Imaging will be recorded at rest and after different stimuli (exercise, hyperthermia and foot lowering).

Detailed Description
-----------------
All the subjects will benefit from a: clinical: diabetes duration, treatments anthropometric: weight, height, BMI level of physical activity by means of the International Physical Activity Questionary, pedometers and the 6 minutes walking test biological evaluations: glycemia, HbA1C, lipids, high sensitive C-reactive protein, fibrinogen, 25(OH)D, creatinine, albumine Type 2 diabetes participants will benefit from neuropathy evaluation: sensory tests by means of Semmes-Weinstein monofilament and of Nerve Check, amplitude and velocity sural nerve and neuropathic symptom score (NSS) In addition, cutaneous microcirculation (perfusion and vasomotion) by means of Laser Doppler Flowmetry and Laser Speckle Imaging will be recorded at rest and after different stimuli (exercise, hyperthermia and foot lowering).

Official Title
-----------------
Microcirculatory Vasomotor Function in Response to Acute Exercise in Type 2 Diabetes With Peripheral Neuropathy

Conditions
-----------------
Diabetic Neuropathy Peripheral, Small Vessel Disease of Diabetes Mellitus, Vasodilation, Vasoconstriction

Intervention / Treatment
-----------------
* Other: Rest
* Other: Exercise
* Other: Foot lowering
* Other: Hyperthermia


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: For diabetic patients, HbA1C >6.5 and diabetes duration >5years For healthy control no diabetes mellitus, no cardiovascular or renal pathology Exclusion Criteria: nondiabetic neuropathy on medication known to affect microcirculation presence of active foot ulcer or wound healing history <3months inability to walk 6 minutes alcohol consumption of more than 3 units per day

Ages Eligible for Study
-----------------
Minimum Age: 40 Years
Maximum Age: 75 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Diagnostic
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Non-neuropathy<br>Type 2 diabetic without neuropathy: Negative findings on Semmes-Weinstein monofilament Neuropathy symptom score (NSS) <3 Negative findings on Nerve Check and Diabetic Peripheral Neuropathy check. Interventions by means of Laser Doppler Flowmetry and Laser Speckle Imaging: rest cutaneous microcirculation (perfusion and vasomotion) Exercise cutaneous microcirculation (perfusion and vasomotion) Foot lowering cutaneous microcirculation (perfusion and vasomotion) Hyperthermia cutaneous microcirculation (perfusion and vasomotion) blood sampling heart rate variability at rest pedometer during 4 days international Physical Activity Questionary Qualify of Life questionary (EQVOD) | Other: Rest<br>* Cutaneous perfusion and vasomotion assessment at rest in supoine position<br>Other: Exercise<br>* Cutaneous perfusion and vasomotion assessment after the 6minute-wlaking test<br>Other: Foot lowering<br>* Cutaneous perfusion and vasomotion assessment after foot lowering<br>Other: Hyperthermia<br>* Cutaneous perfusion and vasomotion assessment during hyperthermia<br>|
| Experimental: Neuropathy<br>Type 2 diabetic with neuropathy Positive findings on Semmes-Weinstein monofilament Neuropathy symptom score (NSS) >3 Positive findings on Nerve Check and Diabetic Peripheral Neuropathy check. Interventions by means of Laser Doppler Flowmetry and Laser Speckle Imaging: rest cutaneous microcirculation (perfusion and vasomotion) Exercise cutaneous microcirculation (perfusion and vasomotion) Foot lowering cutaneous microcirculation (perfusion and vasomotion) Hyperthermia cutaneous microcirculation (perfusion and vasomotion) blood sampling heart rate variability at rest pedometer during 4 days international Physical Activity Questionary Qualify of Life questionary (EQVOD) | Other: Rest<br>* Cutaneous perfusion and vasomotion assessment at rest in supoine position<br>Other: Exercise<br>* Cutaneous perfusion and vasomotion assessment after the 6minute-wlaking test<br>Other: Foot lowering<br>* Cutaneous perfusion and vasomotion assessment after foot lowering<br>Other: Hyperthermia<br>* Cutaneous perfusion and vasomotion assessment during hyperthermia<br>|
| Experimental: Controls<br>matched for age, sexe and BMI with diabetic patients. Interventions by means of Laser Doppler Flowmetry and Laser Speckle Imaging: rest cutaneous microcirculation (perfusion and vasomotion) Exercise cutaneous microcirculation (perfusion and vasomotion) Foot lowering cutaneous microcirculation (perfusion and vasomotion) Hyperthermia cutaneous microcirculation (perfusion and vasomotion) blood sampling heart rate variability at rest international Physical Activity Questionary Qualify of Life questionary (EQVOD) | Other: Rest<br>* Cutaneous perfusion and vasomotion assessment at rest in supoine position<br>Other: Exercise<br>* Cutaneous perfusion and vasomotion assessment after the 6minute-wlaking test<br>Other: Foot lowering<br>* Cutaneous perfusion and vasomotion assessment after foot lowering<br>Other: Hyperthermia<br>* Cutaneous perfusion and vasomotion assessment during hyperthermia<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Changes in average spectral amplitude of the entire frequency range between baseline and after stimulus | Spectral analysis by wavelet analysis | Cutaneous blood flow will be recorded during 20 minutes at rest, 10 minutes after foot lowering, 15 minutes after exercise and 20 minutes during hyperthermia | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
vasomotion